Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-049967

EVP, Research & CSO sold 5,560 shares at $42.92 ($238,632)

  • EVP, Research & CSO acquired 25,560 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-08-25 Option exercise +25,560 $1.53 $39,107 25,560 D
Virgin Herbert EVP, Research & CSO 2020-08-25 Sale −5,560 $42.92 $238,632 20,000 D
Derivatives
Virgin Herbert EVP, Research & CSO 2020-08-25 Option exercise · Stock Option (Right to Buy) −25,560 474,695 D
Open-market sales · 5,560 sh · avg $42.92 · $238,632
Loading xslF345X03/doc4.xml…